- About CTTC
- Invention Disclosure
- News & Events
- Tech Connect
- CTTC MUSE - Blog
- Driving Innovation Forward Newsletter
- MDRAP Town Hall
- Past CTTC Events
Assessment of Right Ventricular Function Using Contrast Echocardiography
Vanderbilt Medical Center researchers have developed a non-invasive and reproducible method of assessing right-ventricular function using contrast-echocardiography. The right-ventricular transit time (RVTT) measures the time needed for echocardiographic contrast to travel from the RV to the bifurcation of the main pulmonary artery. Coupled with the pulmonary transit time (PTT), the time needed for contrast to traverse the entire pulmonary circulation, RVTT is part of a family of diagnostic parameters that can report on RV-specific performance as well as the RV’s function relative to that of the pulmonary circuit as a whole.
Quantification of RV function is vital to the diagnosis and treatment of cardiopulmonary disorders in a myriad of circumstances including heart failure, pulmonary hypertension, prior to cardiac surgery, and in the evaluation for ventricular assist devices/heart transplantation. However, existing methods of RV functional assessment are, in the aggregate, limited by availability, cost, image quality, and contraindications in certain medical conditions.
Figure. A) Short-axis parasternal orientation demonstrating the right ventricular (RV) outflow tract, main pulmonary artery, and pulmonary artery bifurcation (PAB). Also in this view are the left atrium (LA) and aortic valve (AV). The leading edge of the ultrasound contrast injection is seen arriving at the first region of interest (red box) whereas no contrast has arrived at the pulmonary artery bifurcation. B) The same view is demonstrated in which ultrasound contrast has now arrived at the second region of interest at the PAB (yellow box). A third region of interest (blue box) is placed in the left atrium where contrast will arrive several seconds later. C. Intensity-time curves are shown corresponding to the regions of interest defined in panels A and B. Vertical lines are shown representing the arrival of contrast at the RV outflow tract, the PAB, and the LA. The interval between contrast arrival at the RV outflow tract and the PAB is the right ventricular transit time (RVTT). Similarly, the pulmonary transit time (PTT) can be defined as the interval between arrival at the RV outflow tract and LA. The RVTT/PTT ratio can report on the relative contribution of RV function to the overall transit time through the pulmonary circulation.
• Contrast echocardiography is non-invasive, relatively inexpensive, widely available, portable, and conducive to serial measurements (i.e. to assess response to treatment of RV function)
• Potential for incorporation into a variety of echocardiographic platforms
• Unlike cardiac MRI, there are no contraindications for patients with renal dysfunction or pacemakers, defibrillators, and other implantable devices
• Potential for real-time output in graphical or numeric format without off-line post-processing
Intellectual Property Status
• Patent Application has been filed
Inventors:Ken MonahanEvan BrittainSteven BoronyakWilliam Merryman